Delivery Order SPE2DB22D1106-SPE2DB24FDVM0

Award Date 1/17/24
Potential Completion Date 1/18/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $33,761.90 firm-fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The $8,341.15 contract has a completion date of July 22, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA). The $24,489.62 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 11, 2023. The order has an ultimate completion date of August 14, 2023 and is not designated as a set-aside contract. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The $15,073.92 firm fixed price contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Nurtec ODT 75 mg tablets to the federal government. The $5,114.89 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 25, 2023, with a completion date of April 26, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,942.95 firm fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $13,059.66 delivery order is for the supply of the prescription drug Nurtec ODT 75 mg tablets. The contract is a firm-fixed price Delivery Order with an ultimate completion date of April 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,366.26, is for the delivery of Nurtec ODT 75 mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $13,871.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product used for medical treatment. The contract is a firm fixed-price Delivery Order with a period of performance through May 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Nurtec ODT 75 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $5,879.40. It has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDVM0
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Nurtec ODT 75 mg tablets to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,282.25, is a firm fixed-price delivery order with a completion date of January 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 5/13/25, 10:10 AM